Researchers are exploring various treatments for upper eyelid retraction in patients with thyroid-associated ophthalmopathy, including the use of triamcinolone acetonide and botulinum toxin A. Studies are being conducted to evaluate the effectiveness of these treatments, with some focusing on injection methods and others on comparative analyses of different approaches. The management of thyroid eye disease and related conditions, such as Graves' orbitopathy, is also being updated and refined through ongoing research.